Larvol Delta - Evaluating-the-Safety-and-Efficacy-of-AD17002-Intranasal-Spray-in-Treating-Participants-With-Mild-to-Moderate-COVID19

AD17002 - Advagene Biopharma

http://clinicaltrials.gov/ct2/show/NCT05541510

Sep 15, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next